Mohamed F Doheim: Bridging Therapy Improves Outcomes in M2 MCA Occlusions
Mohamed F Doheim, Faculty Instructor (Research) at NIH StrokeNet, shared a post on X:
”Proud to share our new study in Stroke AHA/ASA. In patients with M2 MCA occlusions, bridging therapy (IVT+EVT) was associated with better 90-day functional outcomes compared to EVT alone, with no major safety concerns.”
Read the full article here.
Title: Direct Endovascular Versus Bridging Therapy in M2 Segment Occlusion of Middle Cerebral Artery: A MR CLEAN Registry Study
Authors: Mohamed F. Doheim, Robrecht R.M.M. Knapen, Julie Staals, Wouter J. Schonewille, Diederik W.J. Dippel, Adriaan C.G.M. van Es, Hester F. Lingsma, Christiaan van der Leij, Charles B. Majoie, Raul G. Nogueira, Robert J. van Oostenbrugge, Wim H. van Zwam

Stay updated on the latest scientific advancements with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series